Company: GNMSF
Filing Date: 2025-02-12
Form Type: S-8
Source: 0000947871-25-000131
Chunk: 5

Company: GENMAB A/S
Filing Date: 2025-02-12
Form: S-8
Chunk 5
---
 attorneys-in-fact and agents may deem advisable or necessary to enable the Company to
comply with the Securities Act, and any rules, regulations and requirements of the Commission in respect thereof, in connection with the
registration of the securities or deferred compensation obligations of the Registrant being registered on the Registration Statement (the
“Securities”), including specifically, but without limiting the generality of the foregoing, power and authority to sign,
in the name and on behalf of each of the undersigned, the Registration Statement, any other registration statement under Rule 462(b) of
the Securities Act, or another appropriate form in respect of the registration of the Securities, and any and all amendments thereto,
including post-effective amendments, and any instruments, contracts, documents or other writings of which the originals or copies thereof
are to be filed as a part of, or in connection with, any such registration statement or any other appropriate form or amendments thereto,
and to file or cause to be filed the same with the Commission, and to effect any and all applications and other instruments in the name
and on behalf of each of the undersigned which said attorneys-in-fact and agents deem advisable in order to qualify or register the Securities
under the securities laws of any of the several states or other jurisdictions; and each of the undersigned does hereby ratify all that
said attorneys-in-fact and agents shall do or cause to be done by virtue thereof. Each attorney-in-fact and agent is hereby granted full
power of substitution and revocation with respect hereto.

| Signatures                 
 /s/ Jan                    
 G. J. van de Winkel        
 Jan G. J. van de Winkel    | Title                                                 
 President & Chief Executive Officer                   | Date         
 February 11, 
 2025         |
|:---------------------------|:------------------------------------------------------|:-------------|
|                            | -Principal Executive Officer                          |              |
| /s/ Anthony Pagano         |                                                       |              |
| Anthony Pagano             | Executive Vice President & Chief Financial Officer    | February 11, 
 2025         |
|                            | (Principal Financial Officer and Principal Accounting |              |
|                            | Officer)                                              |              |
| /s/ Deirdre P. Connelly    |                                                       |              |
| Deirdre P. Connelly        | Chair of the Board of Directors                       | February 11, 
 2025         |
| /s/ Pernille Erenbjerg     |                                                       |              |
|